Efficacy and safety of leuprolide acetate 6-month depot for suppression of testosterone in patients with prostate cancer

BACKGROUND: This open-label study evaluated the efficacy and safety of a new leuprolide acetate 45 mg 6-month depot formulation in 151 men with prostate cancer who received 2 intramuscular injections administered 24 weeks apart. METHODS: The primary efficacy measurement was the proportion of patient...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Spitz, A, Young, J M, Larsen, L, Mattia-Goldberg, C, Donnelly, J, Chwalisz, K
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2012
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3278745/
https://ncbi.nlm.nih.gov/pubmed/22025196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/pcan.2011.50
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky